Skip to content

Study of the Biological Function of Muscle Satellite Cells From Patients With Obstetric Brachial Plexus Palsy

Study of the Biological Function of Muscle Satellite Cells From Patients With Obstetric Brachial Plexus Palsy Satellite Cell Obstetrical PlExus (SCOPE)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05403034
Acronym
SCOPE
Enrollment
8
Registered
2022-06-03
Start date
2022-10-17
Completion date
2025-06-25
Last updated
2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetrical Brachial Plexus Palsy

Keywords

Brachial plexus, Neonatal brachial plexus palsy, Denervation, Muscle atrophy, Muscle regeneration, Botulinum toxin, Satellite cell, Primary human muscle cell culture

Brief summary

The purpose of this prospective work is to study the consequences of obstetrical brachial plexus paralysis on the rotator muscles of the shoulder. The hypothesis is that shoulder stiffness of these children is due to an impairment of the shoulder rotator muscles. The investigators want to test the regenerative capacities of these muscles. The development of a cellular model of this pathology will allow to test new therapeutic perspectives and to validate our hypothesis.

Detailed description

During delivery, there can be a lesion of the nerve roots of the brachial plexus (cervical C5-C8 and/or thoracic T1 roots). The newborn presents at birth a paralysis of the arm (Obstetrical Brachial Plexus Paralysis: OBPP). One third of children with OBPP will have sequelae despite daily rehabilitation. The most frequent disability is shoulder stiffness. The current hypothesis is that this stiffness is due to a permanent imbalance between the affected shoulder muscles (lateral rotators) and the muscles less affected by the paralysis (medial rotators). Because of this imbalance, the injured shoulder is spontaneously positioned in medial rotation. This position would lead to retractions at the front of the joint despite rehabilitation. In case of incomplete recovery, growth disorders of the shoulder joint (dysplasia) appear as well as a functional handicap. The management, from the age of 2 years, in case of shoulder stiffness and dysplasia, is surgery (arthrolysis) to regain mobility. During this operation, a muscle transfer can also be performed to strengthen the lateral rotator muscles. However, despite surgery, mobility deficits often recur within a few years. To understand the origin of the lateral and medial rotation deficits, the investigators conducted an anatomopathological study of the rotator muscles in these children. The preliminary results show a significant damage of the rotator muscles with the presence of fibrosis which could explain the rotational stiffness and the functional impairment. To better understand the pathophysiological mechanisms, the investigatorswill set up an OBPP model in cell culture to understand the regenerative capacities and to test new pharmacological approaches.

Interventions

PROCEDUREMuscle biopsy

Peroperative muscle biopsy will be performed during a planned shoulder surgery (arthrolysis and/or muscle transfer)

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER
Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* OBPP children with a planned shoulder surgery (arthrolysis and/or muscle transfer).

Exclusion criteria

* other neurological disorders, post-traumatic shoulder stiffness

Design outcomes

Primary

MeasureTime frameDescription
Assessment of muscle regeneration capacity: proliferation capacity30 daysProliferation capacity of satellite cells assessed by immunofluorescence: percentage of Pax 7 positive cells/total desmin positive cells
assessment of muscle regeneration capacity: differenciation capacity30 daysDifferentiation capacity of satellite cells assessed by histology: fusion index (number of nuclei in a myotubule compared to total number of nuclei in the sample) in percentage

Secondary

MeasureTime frameDescription
Effect of botulinum toxin on the proliferation potential of satellite cells: proliferation capacity30 daysProliferation capacity of satellite cells assessed by immunofluorescence: percentage of Pax 7 positive cells/total desmin positive cells.
Effect of botulinum toxin on the proliferation potential of satellite cells: differentiation capacity30 daysDifferentiation capacity of satellite cells assessed by histology: fusion index (number of nuclei in a myotubule compared to total number of nuclei in the sample) in percentage

Countries

France

Contacts

PRINCIPAL_INVESTIGATORMarion DELPONT, Dr

University Hospital, Montpellier

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 19, 2026